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Lactobacilli are human commensals found in the gastrointestinal and genitourinary tract. 
Although generally conceived as non-pathogenic microorganisms, the existence of sev-
eral reports implicating them in certain severe pathological entities renders this species 
as opportunistic pathogens. The case of a 58-year-old woman with mixed Lactobacillus 
infection is described. The patient was admitted in an outpatient clinic with commu-
nity acquired pneumonia, and on the third day of hospitalization she presented rapid 
pneumonia deterioration. Subsequent imaging techniques revealed increased pleural 
empyema in alignment with the general deterioration of her clinical condition. Pleural 
fluid culture revealed the presence of Lactobacillus delbrueckii and Lactobacillus gasseri 
and the infection was successfully treated with clindamycin. Five months after hospital 
discharge and an overall good condition, the patient developed signs of dysphagia and 
upon re-admission an inoperable esophageal carcinoma was diagnosed. The patient 
succumbed to the cancer 11 months later. Herein, we report for the first time a mixed 
respiratory infection due to lactobacilli, possibly associated with a formerly unveiled 
esophageal malignancy.
Keywords: Lactobacillus delbrueckii, Lactobacillus gasseri, pneumonia, pleural empyema, bacterial translocation, 
esophageal carcinoma
INtRoDUCtIoN
Herein, we report the case of a woman who developed pneumonia and empyema due to a 
mixed Lactobacillus delbrueckii and Lactobacillus gasseri infection. Intriguingly, this mixed 
lactobacilli lung and pleural infection was associated with a formerly unveiled esophageal 
malignancy.
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Case Report
A 58-year-old woman (smoker, 30  packs/year) with no past 
medical history was admitted to the outpatient Pulmonary 
Department of the Athens Medical Center for the evaluation of 
fever and dyspnea 4 days before admission. Two days before, the 
patient received empirical treatment with orally administered 
moxifloxacin (400  mg/day) and oseltamivir (75  mg/12  h) for 
community acquired pneumonia (CAP). Upon admission, 
clinical and laboratory testing as well as echocardiogram, chest 
X-ray (CXR), and chest computerized tomography (CCT) with 
intravenous contrast material were performed.
On examination upon first admission, the patient appeared 
with normal appetite and no apparent weight loss. She was 
febrile (38.5°C) without chills and hypoxic with oxygen satura-
tion (SO2) of 94% on room air. On auscultation, dullness and 
decreased breath sounds were noted over the left lower chest. 
The echocardiogram was normal. Her blood tests demonstrated 
elevated white blood cells (WBC) count (10,760  cells/μL, neu-
trophils 81%), erythrocyte sedimentation rate (ESR) (102 mm/h, 
control < 30 mm/h), and C-reactive protein (CRP) (36.1 mg/dL, 
control < 0.5 mg/dL). Repeated blood cultures and urinary anti-
gen tests for Pneumococcus and Legionella were negative. CXR 
(Figure 1A) and CCT (Figure 1B) on the admission day showed 
left-sided pleural effusion with consolidation and atelectasis of 
the left lower lung field.
The patient continued the treatment for CAP complicated by 
pleural effusion, with intravenous moxifloxacin (400  mg/day) 
and supplemental oxygen therapy. However, on the third day 
of hospitalization, her clinical condition dramatically deterio-
rated with severe dyspnea, without orthopnea (respiratory rate 
30 breaths/min), hypoxemia (SO2 of 92% on a FiO2 100%), and 
fever (38.9°C). The new CXR (Figure 1C) and CCT (Figure 1D) 
revealed a significant increase of the left-sided pleural effusion 
with compressive atelectasis of the left lung and development of 
extensive consolidations in the right lung, especially in the upper 
lung fields. Moxifloxacin was discontinued and followed by the 
administration of intravenous meropenem (1  g/8  h), amikacin 
(500 mg/12 h), and linezolid (500 mg/12 h).
Chest drainage was performed and pleural fluid analysis 
exhibited elevated WBC count (14,850  cells/μL, neutrophils 
95%) and lactate dehydrogenase (LDH) levels (1257  U/L), 
decreased levels of glucose (2  mg%), and pH 7.0. Pleural fluid 
Gram-stain showed the presence of Gram-positive bacilli and was 
both aerobically and anaerobically cultured. After 48 h incuba-
tion, two morphologically distinct types of Gram-positive rods 
colonies appeared. The bacterial isolates were oxidase-negative, 
catalase-negative, and non-motile. Both isolates were preliminary 
identified as Lactobacillus spp.
Species identification was performed using a previ-
ously described 16S polymerase chain reaction (PCR) and 
sequencing protocol (1, 2). Total DNA was extracted from 
bacterial colonies harvested from the agar plates using the 
commercially available QIAamp DNA Mini Kit (Qiagen, 
Hilden, Germany) and the tissue protocol, according to the 
manufacturer’s instructions. PCR was performed using the 
GoTaq Hot Start Colorless Master Mix (Promega Corp., 
Madison, WI, USA) and a MyCycler Thermal Cycler (Bio-Rad 
Laboratories MEPE, Athens, Greece) in 50 μL final reaction 
volumes. PCR products were visualized under UV illumination 
and purified using the NucleoSpin Gel and PCR Clean-up kit 
(Macherey Nagel GmbH, Düren, Germany). Sanger sequenc-
ing was performed in a 3130 Genetic Analyzer (Applied 
Biosystems Life Technologies Ltd., Paisley, UK). Sequencing 
results were aligned and edited using the Data Analysis in 
Molecular Biology and Evolution (DAMBE) software ver. 5.1.5 
(University of Ottawa, Ottawa, ON, Canada). The consensus 
sequence results that were obtained were compared with those 
submitted to the GenBank using the BLAST algorithm. The 
isolates were identified as L. delbrueckii (16S accession number 
KU207148) and L. gasseri (16S accession number KU207149). 
The pure isolation of the L. delbrueckii and L. gasseri strains 
in the culture of pleural fluid and their further molecular 
identification were suggestive of extraintestinal colonization 
and infection by these two species. It was suspected that the two 
lactobacilli strains were involved in the clinical manifestations 
of pneumonia and empyema.
Susceptibility testing was performed according to the guide-
lines of the European Committee on Antimicrobial Susceptibility 
Testing (EUCAST) for Gram-positive anaerobes using the E-test 
diffusion method, on Mueller–Hinton agar supplemented 
with 5% mechanically defibrinated horse blood and 20  mg/L 
β-Nicotinamide adenine dinucleotide (β-NAD) (MH-F) for 
48 h at 37°C in anaerobic conditions. Antibiotics with available 
breakpoints were tested [minimum inhibitory concentration 
(MIC) values in milligrams per Liter; S = susceptible, R = resist-
ant]: ampicillin (0.5; S), amoxicillin–clavulanic acid (0.25; S), 
ampicillin–sulbactam (0.5; S), ticarcillin–clavulanic acid (0.25; 
S), piperacillin–tazobactam (0.25; S), imipenem (0.25; S), mero-
penem (0.25; S), clindamycin (0.25; S), and vancomycin (>32; R). 
Fluoroquinolones were not included as lactobacilli bear intrinsic 
resistance to this antimicrobial class and respective breakpoints 
are not available.
Following identification of Lactobacillus species and suscepti-
bility testing, intravenous clindamycin (600 mg/6 h) was added to 
the antibiotic regimen. The patient presented steady improvement 
with complete symptom resolution and clearance of the abnormal 
findings in the CCTs (Figures 1E,F).
During a 5-month follow-up, referring to the preceding 
respiratory tract infection, the patient exhibited no clinical signs 
and symptoms, as ascertained by standard clinical examination 
and routine laboratory tests with normal values (blood cell 
count, ESR and CRP, blood glucose, creatinine, and enzymes). 
However, on the fifth month after hospital discharge, she 
developed signs of dysphagia. Subsequent gastroscopy and 
biopsy revealed an inoperable esophageal carcinoma (invasive 
squamous cell carcinoma–SCC) localized in the lower thoracic 
esophagus proximal to the gastroesophageal junction. Thorough 
retrospective reconsideration of the imaging examinations (CXR, 
CCT, and CT of the upper and lower abdomen) performed on 
admission and during hospitalization did not reveal any signs of 
prior esophageal malignant process. The patient succumbed to 
the cancer 11 months later.
FIGURe 1 | (a) CXR and (B1–B3) CCTs with intravenous contrast material on the admission day exhibit left-sided pleural fluid with consolidation and atelectasis of 
the left lower lung field. (C) CXR and (D1–D3) CCTs on the third day of admission. They exhibit significant increase of the left-sided pleural effusion with compressive 
atelectasis of the left lung and development of extensive consolidations in the right lung, especially in the upper lung fields. Small air collections are present in the 
pleural fluid. The chest drainage tube can be seen on the left of the CXR. (e) CXR 20 days and (F1–F3) CCT 40 days after the patient discharge from the hospital. 
They show complete resolution of the lung consolidations, limited left pleural thickening, and minimal pleural fluid (1: upper lung fields, 2: middle lung fields, 3: lower 
lung fields). CXR, chest X-ray; CCT, chest computerized tomography.
3
Chaini et al. Lactobacillus-Associated Pneumonia and Empyema
Frontiers in Medicine | www.frontiersin.org September 2016 | Volume 3 | Article 42
BaCKGRoUND
Lactobacilli are human commensals of the gastrointestinal 
and genitourinary tract. They are facultative anaerobic, non-
sporing, non-motile, lactic acid producing Gram-positive rods. 
Lactobacillus species safety in the production of food supplements 
has been established worldwide for their common use as probi-
otics that exert pronounced beneficial activity (3). Nevertheless, 
probiotics as viable organisms may contribute to host infection 
under specific circumstances. Pathological entities related with 
lactobacilli as opportunistic pathogens include several life-
threatening conditions such as bacteremia, sepsis, endocarditis, 
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pneumonia, abscess formation, peritonitis, urinary tract infec-
tions, meningitis, and Fournier’s gangrene (1–10). Bacteremia 
and endocarditis are the most common Lactobacillus-associated 
infections, while pneumonia and empyema are rarer (9, 11–13).
Research and pilot studies concerning the effectiveness of 
probiotic therapy in the prevention of nosocomial pneumonia in 
critically ill patients (ventilator-associated pneumonia, VAP) has 
provided ambiguous results, either supporting clinical benefit 
or no benefit at all. The beneficiary effect lies in the fact that 
probiotic supplements enhance the protective activity of the gut 
microbiome with subsequent upregulation of immune defense, 
leading to an overall reduction of pathogens growth (14, 15). 
However, the use of these low virulent microorganisms as pro-
biotics in immunocompromised patients has also raised safety 
concerns when applied to patients (a) with known comorbidities 
(history of heart defects, cardiac valves and prostheses, gastroin-
testinal injury), (b) after invasive procedures (hematological or 
organ transplantation), and (c) under chronic immunosuppress-
ing medication (16). Extensive use of probiotics even as part of 
the therapeutic protocol for specific pathological conditions 
without enough information about the susceptibility and the 
translocation rate of each strain could result in late diagnosed 
infections (3).
In 1989, Querol et al. described two cases of pneumonia and 
empyema out of 28 previously reported Lactobacillus infection 
cases (13), while in 2014, Doern et  al. identified 11 cases of 
Lactobacillus pneumonia (12). A current review of the literature 
revealed 15 cases of Lactobacillus pneumonia, while empyema 
was reported in 4 out of the 15 cases (8, 9, 11–13, 17–25). In 
the 15 previously described cases of Lactobacillus-attributed 
pneumonia, the documented Lactobacillus species were L. casei 
ssp. rhamnosus (18, 19), L. rhamnosus (12, 17), and L. casei (22, 
24). L. delbrueckii and L. gasseri are rarely identified as infection 
causative agents (26). However, there have been scarce reports 
linking the two commensals with bacteremia and urinary tract 
infections (5, 6, 11, 27). Four previously reported pneumonia 
and empyema cases were associated with underlying clinical 
conditions (gastro-pleural fistula, tracheo-esophageal fistula cre-
ated by an esophageal carcinoma, impaired local lung immune 
system due to emphysema and bacteremia) (8, 9, 13, 17). The 
remaining 11 cases of pneumonia were associated with chronic 
myeloid leukemia, heavy smoking and pulmonary emphysema, 
neutropenia, transmission of Lactobacillus by probiotics in 
patient with lung transplantation, acquired immune deficiency 
syndrome (AIDS), VAP in a critically ill trauma patient, and with 
probiotic-associated aspiration (12, 18–25).
Pulmonary empyema, and pyopneumopericardium, caused 
by commensals of the upper respiratory tract (Pseudomonas 
aeruginosa, Streptococcus group D and G) have been previously 
associated with esophageal cancer (4). The most common form of 
esophageal cancer is SCC, a malignant epithelial tumor with squa-
mous cell differentiation (28). Smoking and alcohol consumption 
have been among the major risk factors, while the carcinogenicity 
of the human papillomavirus (HPV) has been also associated 
with the disease (29). Esophageal cancer is usually advanced at 
presentation, and therefore it accounts as the eighth cause of can-
cer worldwide (30). The most common symptom of a patient with 
SCC is dysphagia; however, the assessment of esophageal cancer 
is not always easy due to the increasing number of asymptomatic 
patients. Additionally, it may be underdetermined by typical 
diagnostic tools; barium esophagography is only proceeded in 
symptomatic patients but the confirmation of the diagnosis is 
made through esophagogastroscopy and biopsy (7). Overall, no 
specific data exist concerning the time elapsing between the onset 
of the malignancy and the clinical manifestations.
When it comes to the association of cancer with the use of 
Lactobacillus species as probiotics, literature supports the protec-
tive role of these supplements toward several types of cancer. The 
protective activity of Lactobacillus species have been profound in 
colorectal, urinary bladder, and breast cancer, mainly due to the 
cytotoxic and antiproliferative role of their fermentation products 
against cancer cells (31–33). However, Lactobacillus-associated 
infections have been implicated in the land of preexisting malig-
nancy, constituting severe medical conditions. To date, only 
one case of esophageal carcinoma associated with Lactobacillus 
pneumonia has been reported (13).
Lactobacilli have been placed among the prevailing bacterial 
milieu of the upper and lower esophageal mucosal linings (34, 
35). The rather uncommon localization of Lactobacillus isolates 
in the lung could be therefore attributed to passive translocation 
through a possible communication of the anatomical structures. 
Indeed, a previously reported case of Lactobacillus-associated 
pneumonia complicated by empyema was secondary to a defined 
tracheo-esophageal fistula created by esophageal carcinoma in 
a patient tagged with severe risk factors (smoking more than 
40 packs/year, heavy alcohol consumption, septic mouth due to 
multiple carious teeth, and hypoproteinaemia). In both cases, the 
fatal clinical course was attributed to the basal status of the two 
patients and not in the Lactobacillus pathogenicity (13). It should 
be noted that in both patients primary imaging techniques were 
negative for abnormal findings suggestive of esophageal cancer. 
In our case, after the diagnosis of esophageal cancer, independ-
ent revaluation of the CCTs by two radiologists confirmed the 
absence of prior abnormalities. In addition, CT with contrast 
material of the upper and lower abdomen did not present findings 
suggestive of malignancy at an earlier stage.
INFoRMeD CoNseNt stateMeNt
Written informed consent is not required if data is drawn from 
observed behavior or if data does not contain identifying infor-
mation, as it is in the present report.
DIsCUssIoN
Lactobacilli are ubiquitous commensals of the mucosal surfaces 
of the gastrointestinal and genitourinary tract. Despite being rare, 
there has been reported causality between the bacteria and vari-
ous infections in immunocompromised individuals. However, in 
most cases, the true prevalence of lactobacilli-associated infec-
tions is underestimated as the bacterium is typically regarded 
as commensal or occasional contamination; thus, debate exists 
concerning the clinical significance of lactobacilli isolation from 
normally sterile specimens.
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While most of the pneumonia cases are attributed to single 
bacterial or viral infection, there have been reports on mixed 
CAP cases that follow the general pattern of (i) dual viral, (ii) 
viral plus bacterial, and (iii) dual bacterial. In the latter pattern, 
a Streptococcus pneumoniae infection is usually accompanied by 
Haemophilus influenzae or an atypical pathogen (Legionella pneu-
moniae, Chlamydia pneumoniae, and Mycoplasma pneumoniae) 
(36–38). In this case, the causal relationship of L. delbrueckii and 
L. gasseri isolates with pneumonia and empyema is supported 
for the first time, suggesting coinfection from different species 
of the same genus. The case of pneumonia and empyema, with 
the partition of both lactobacilli isolated from a sterile site along 
with the systemic inflammatory reaction confirmed by labora-
tory evaluation and a molecular technique, strongly suggests 
the two bacterial species as the causative microorganisms of the 
mixed infection. However, the etiology defining the pathoge-
netic background of the infection and the lactobacilli portal of 
entry is rather puzzling. The existence of a mixed Lactobacillus 
infection and the possible correlation with the pre-existence of 
a malignancy was the central observation in this case. Lab and 
clinical findings are influenced by two major risk factors: (a) 
heavy smoking directly related with the potential of preexisting 
undiagnosed esophageal carcinoma and (b) moxifloxacin treat-
ment. Regarding the patient’s history, she denied any previous 
use of probiotic preparations, and the provided history did not 
reveal interventions that could alter the normal gastrointestinal 
flora. Therefore, the possibility of acquiring the infectious strains 
through prior use of probiotic preparations or from ingested 
foods may be considered insignificant.
The antibiotic treatment may also cause lactobacilli selection 
through an uncharted infection acquisition mechanism. Prior 
ineffective therapy with moxifloxacin could be considered as a 
risk factor for Lactobacillus population resistance, bacteremia, 
and translocation (39, 40). The susceptibility profile of L. del-
brueckii and L. gasseri was similar with those previously reported. 
Lactobacilli are generally susceptible to penicillin, ampicillin, 
clindamycin, erythromycin, and cephalothin (5, 13). Antibiotics 
modify the intestinal flora thus enhancing the procedure of 
translocation; the presence of the mixed lactobacilli population 
could be attributed in this mechanism (41).
Empyema constitutes a life-threatening infection that is 
associated with several underlying medical conditions such as 
lung cancer, alcoholism, and conditions that carry the risk of 
aspiration (critically ill patients, comatose patients, neurologi-
cal disorders). In the post-antibiotic era, literature is suggestive 
that high isolation rates of anaerobic Gram-positive bacteria 
from pleural specimens imply their leading role in most cases of 
empyema (42, 43). Anaerobic infections usually derive from the 
relatively low virulent normal flora that is prevalent in infections 
associated with predisposing or underlying medical conditions, 
thus giving the opportunistic pathogens the ability to establish 
infection through deeper tissue penetration. Another hint, which 
is supported by literature and is also present in this case, is the fact 
that opportunistic pathogens are often mixed with other anaero-
bic or aerobic bacteria (44). Therefore, the immunomodulatory 
impact of lactobacilli along with pleural fluid settlement through 
blood flow could be indirectly indicative of an underlying disease 
and the absence of overt esophageal carcinoma symptoms either 
before or during hospitalization does not exclude the possibility 
of underlying malignancy.
CoNCLUDING ReMaRKs
To date, this is the first report of a mixed CAP case complicated 
by empyema which is attributed to different species of the same 
genus. Additionally, L. delbrueckii and L. gasseri are herein impli-
cated in the pathogenesis of a complicated lower respiratory tract 
infection. Despite the common belief that that lactobacilli are 
uncommon pathogens, the identification in extra-intestinal or 
extra-genitourinary sites of infection should not be overlooked. 
This case indicates that the detection of lactobacilli may serve 
as a probable early sign of an underlying but not yet unveiled 
potentially fatal condition.
The fatal clinical course in the majority of the cases com-
plicated with Lactobacillus-associated infections is attributed 
to the underlying status. This case corroborates the aspect that 
microbial pathogenicity is indefinable and depends on the ad hoc 
host–microbe interaction. In clinical cases associated with infec-
tious disorders, every microorganism isolated from naturally 
sterile clinical specimens, should be considered as a putative 
causative agent warranting further investigation.
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